Clinical Trials Browser

OTHER × Breast Neoplasms × sapanisertib × Clear all

NCT02988986 2021-09-22

ANETT

Phase 2 Completed

28 enrolled 9 charts

Breast Neoplasms

NCT02619669 2020-03-12

Neoadjuvant Run-In Study With TAK-228 Followed by Letrozole/TAK-228 in Women With High-Risk ER+/HER2- Breast Cancer

Phase 1 Withdrawn

Breast Neoplasms